Tekla Healthcare Investors (HQH)
NYSE NYSE Primary NASDAQ (NMS) 
I Am Loading Up Big Dividends For My Golden Years
Innovation, demand, and shortage of providers have kept healthcare inflation significantly higher than the CPI. Regardless of the political scene, the aging U.S. population and rising chronic illnesses are undeniable truths to face. Income investing ensures consistent returns, allowing flexibility in financial planning, despite volatile stock prices.
HQH: Improved Fundamentals, Strong Dividend Support
HQH offers a high dividend yield of 13.6%, making it attractive for income-focused investors, despite potential tax consequences. The fund trades at a 7.86% discount to NAV, presenting a good entry point, especially with anticipated interest rate cuts and increased healthcare spending. HQH's portfolio is heavily concentrated in Biotechnology (64.6%), posing sector-specific risks but also benefiting from projected growth in biotech and healthcare spending.
Don't Miss The Dividend Train, Yields Up To 15%
For over 400 years, dividends have been a steady form of capital from the markets to your account. Dividends can generate dependable and powerful paychecks. We discuss two big yields from dependable sectors.
HQH: Not For Income Investors
I maintain a sell rating on the abrdn Healthcare Investors fund due to its incongruence with income investing and managed distribution plans. HQH has underperformed the Nasdaq Biotechnology Index and iShares Biotechnology ETF, highlighting its inability to generate alpha versus more tax-efficient alternatives. The fund's high yield is unsustainable, relying on capital gains and potentially forcing premature sales, which is unsuitable for income-oriented investors.
HQH: Declines Bring Potential Opportunity
HQH has seen pressure recently due to regulatory uncertainty; while the closed-end funds discount has actually narrowed, it could be an interesting place to put some capital to work. The fund's 12% managed distribution policy has attracted interest from yield investors, though a quarterly pay may be less appealing. HQH's portfolio is tilted toward a heavier weight in biotech, with top holdings like Gilead Sciences showing resilience while others like Regeneron and Eli Lilly have struggled.
HQH: High Yielding Exposure To Biotech With Positive Outlook
abrdn Healthcare Investors operates as a closed end fund that aims to provide total returns comprised of high current income. HQH offers a high-yielding dividend rate of 12.7% and distributions are paid out on a monthly basis. The fund's focus on biotech holdings makes it vulnerable to interest rate changes but also positions it for potential growth with lower rates.
HQH: Discount Remains Attractive With A Now Higher Distribution Rate
The healthcare sector is traditionally defensive during economic downturns, but not all industries within the healthcare sector are created equal. abrdn Healthcare Investors Fund focuses on the more cyclical biotech space, with over half of its portfolio allocated there. HQH's managed distribution policy was increased significantly since our prior update, which was a factor in the funds discount narrowing, but it continues to trade at an attractive discount.
HQH: Double-Digit Discount And Dividend Ready For Biotech Rally
HQH features a deep NAV discount at 11%, it is cheap and offers good opportunity for price appreciation. Biotech sector is showing strength in recent market rally. HQH with high yield at 13% is a good buy for income investors to participate the promising biotech rally. Record financing activities in the sector fuel the business growth and set up for a sustainable market recovery.
Make Money While You Sleep, 2 Big Dividends For A Retirement Dream
What is your dream retirement? Make goals to achieve it. Don't make monetary number goals that can't answer the "what then?" question. I meet expenses head-on with highly valuable income.
abrdn U.S. Closed-End Funds Announce Results of Annual Meeting of Shareholders
PHILADELPHIA, PA / ACCESSWIRE / June 26, 2024 / The following abrdn U.S. Closed-End Funds (NYSE:HQH)(NYSE:THQ)(NYSE:THW) announced they each held their Annual Meeting of Shareholders (the "Meetings") on June 25, 2024. At the Meetings, shareholders of the respective Funds voted on the proposals set forth below: abrdn Healthcare Investors ("HQH") As of the record date, April 1, 2024, HQH had outstanding 50,624,847 shares of common stock.
2 Magnificent Funds To Generate Passive Income
$7.1 trillion is invested in passive ETFs, rocking the market with their inflows and outflows. Few passive ETFs help you achieve specific goals. We look for options to meet our income needs for a lifetime.
Private Advisor Group LLC Acquires 4,337 Shares of Abrdn Healthcare Investors (NYSE:HQH)
Private Advisor Group LLC raised its holdings in Abrdn Healthcare Investors (NYSE:HQH – Free Report) by 16.0% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 31,510 shares of the financial services provider’s stock after purchasing an additional 4,337 shares during the quarter. Private Advisor Group LLC owned approximately 0.07% of Abrdn Healthcare Investors worth $522,000 as of its most recent SEC filing. A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Blue Bell Private Wealth Management LLC raised its holdings in shares of Abrdn Healthcare Investors by 76.6% in the fourth quarter. Blue Bell Private Wealth Management LLC now owns 10,420 shares of the financial services provider’s stock valued at $173,000 after buying an additional 4,520 shares during the last quarter. Milestone Asset Management LLC acquired a new stake in Abrdn Healthcare Investors in the 4th quarter valued at about $212,000. WNY Asset Management LLC acquired a new position in shares of Abrdn Healthcare Investors during the third quarter worth approximately $213,000. Capital Investment Advisory Services LLC lifted its position in shares of Abrdn Healthcare Investors by 6.6% during the fourth quarter. Capital Investment Advisory Services LLC now owns 16,238 shares of the financial services provider’s stock worth $269,000 after purchasing an additional 1,000 shares in the last quarter. Finally, Atomi Financial Group Inc. grew its stake in shares of Abrdn Healthcare Investors by 11.0% during the third quarter. Atomi Financial Group Inc. now owns 20,094 shares of the financial services provider’s stock valued at $312,000 after purchasing an additional 1,992 shares during the last quarter. Institutional investors and hedge funds own 32.60% of the company’s stock. Abrdn Healthcare Investors Stock Performance HQH stock opened at $17.42 on Monday. The company has a 50 day moving average price of $16.56 and a 200 day moving average price of $16.45. Abrdn Healthcare Investors has a fifty-two week low of $14.31 and a fifty-two week high of $17.68. Abrdn Healthcare Investors Increases Dividend The company also recently announced a quarterly dividend, which will be paid on Friday, June 28th. Stockholders of record on Thursday, May 23rd will be given a dividend of $0.59 per share. The ex-dividend date is Wednesday, May 22nd. This represents a $2.36 dividend on an annualized basis and a dividend yield of 13.55%. This is an increase from Abrdn Healthcare Investors’s previous quarterly dividend of $0.48. About Abrdn Healthcare Investors (Free Report) Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. Read More Five stocks we like better than Abrdn Healthcare Investors Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours? MarketBeat Week in Review – 5/13 – 5/17 Low PE Growth Stocks: Unlocking Investment Opportunities Take-Two Interactive Software Offers 2nd Chance for Investors Investing in Commodities: What Are They? How to Invest in Them Deere & Company’s Q2 Report: Strong Revenue, Cautious Outlook Want to see what other hedge funds are holding HQH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Abrdn Healthcare Investors (NYSE:HQH – Free Report).
